-   Diabetic (
-   -   FDA: Dangerous genital infection linked to common diabetes meds (

Dick 03-09-2018 12:26 AM

FDA: Dangerous genital infection linked to common diabetes meds

(CBS) The U.S. Food and Drug Administration is issuing a warning
about a certain class of type 2 diabetes medicine following
reports of serious genital infections and one death.

The bacterial infection of the genitals and area around the
genitals is called necrotizing fasciitis of the perineum, also
called Fournier's gangrene. The bacteria typically enter the
body through a cut or break in the skin.

In a news release, the FDA says between March 2013 and May 2018,
12 cases of Fournier's gangrene were identified in patients
taking an SGLT2 inhibitor.

Fournier's gangrene developed within several months after the 12
patients starting taking an SGLT2 inhibitor, and use of the drug
was stopped in most cases. All 12 patients were hospitalized and
required surgery. Some patients required multiple disfiguring
surgeries, some developed complications, and one patient died.

According to the FDA, 1.7 million patients in the U.S. filled
prescriptions for an SGLT2 inhibitor at outpatient retail

The FDA warns that patients should seek medical attention
immediately if they experience any symptoms of tenderness,
redness, or swelling of the genitals or the area from the
genitals back to the rectum, and have a fever above 100.4 F or a
general feeling of being unwell.

Marie Kristy 06-09-2018 01:23 PM

Very useful information.

T[_8_] 07-09-2018 10:55 PM

FDA: Dangerous genital infection linked to common diabetes meds
On 09/06/2018 05:23 AM, Marie Kristy wrote:
Very useful information.

My opinion, all allopathic drugs for Diabetes will
end their life cycles in a class action suite.
I can't wait to sign up for metformin's.

Best to return to your ancestral diet. Called Primal
or Paleo. The Alaska Indians also have a name for
it, but I lost it. I have been drug free for over
five years now.

All times are GMT +1. The time now is 04:36 PM.

Powered by vBulletin® Copyright ©2000 - 2021, Jelsoft Enterprises Ltd.